News + Filings Transactions
|
ATWOOD BRIAN G
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $1.18 | $14.2k | | 06/13/2023 |
| 06/08/2022 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $2.09 | $25.1k | | 06/08/2022 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Class B Common Stock | 25k | $0.00 | $0 | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 06/10/2021 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 42.2k | $5.97 | $252.1k | | 06/10/2021 |
| 06/09/2021 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $10.27 | $123.2k | | 06/09/2021 |
| 01/12/2021 | eFFECTOR Therapeutics, Inc. | | Other (disposition) | Class B Common Stock | 25k | $0.00 | $0 | By LWAC D&O LLC | 01/12/2021 |
| 12/09/2020 | Atreca, Inc. | BCEL | Gift | Stock Option (right to buy) | 12k | $17.87 | $214.4k | | 12/09/2020 |
| 12/09/2020 | Atreca, Inc. | BCEL | Gift | Stock Option (right to buy) | 12k | $17.87 | $214.4k | By Atwood-Edminster Trust dtd 4/2/00 | 12/09/2020 |
| 12/09/2020 | Atreca, Inc. | BCEL | Gift | Stock Option (right to buy) | 12.5k | $4.56 | $57k | | 12/09/2020 |
| 12/09/2020 | Atreca, Inc. | BCEL | Gift | Stock Option (right to buy) | 12.5k | $4.56 | $57k | By Atwood-Edminster Trust dtd 4/2/00 | 12/09/2020 |
| 12/09/2020 | Atreca, Inc. | BCEL | Gift | Stock Option (right to buy) | 34.2k | $12.66 | $432.5k | | 12/09/2020 |
| 12/09/2020 | Atreca, Inc. | BCEL | Gift | Stock Option (right to buy) | 34.2k | $12.66 | $432.5k | By Atwood-Edminster Trust dtd 4/2/00 | 12/09/2020 |
| 11/09/2020 | Clovis Oncology, Inc. | CLVS | Exercise | Stock Option (right to buy) | 6.9k | $3.08 | $21.2k | | 11/09/2020 |
| 06/10/2020 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $17.87 | $214.4k | | 06/10/2020 |
| 06/04/2020 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 40.1k | $6.48 | $260.1k | | 06/04/2020 |
| 08/20/2019 | Clovis Oncology, Inc. | CLVS | Exercise | Stock Option (right to buy) | 25.9k | $0.29 | $7.5k | | 08/20/2019 |
| 06/24/2019 | Atreca, Inc. | BCEL | Conversion | Class A Common Stock | 8.8k | $0.00 | $0 | By Atwood-Edminster Trust | 06/24/2019 |
| 06/24/2019 | Atreca, Inc. | BCEL | Conversion | Series A Preferred Stock | 4.5k | $0.00 | $0 | By Atwood-Edminster Trust | 06/24/2019 |
| 06/24/2019 | Atreca, Inc. | BCEL | Conversion | Series B Preferred Stock | 4.3k | $0.00 | $0 | By Atwood-Edminster Trust | 06/24/2019 |
| 06/06/2019 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 28.9k | $14.66 | $423.4k | | 06/06/2019 |
| 10/11/2018 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 14.8k | $27.92 | $412.4k | | 10/11/2018 |
| 06/26/2017 | Clovis Oncology, Inc. | CLVS | Other (acquisition) | Common Stock | 5k | $0.00 | $0 | See Footnote | 06/26/2017 |
| 06/26/2017 | Clovis Oncology, Inc. | CLVS | Other (acquisition) | Common Stock | 212 | $0.00 | $0 | See Footnote | 06/26/2017 |
| 06/08/2017 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 10k | $59.56 | $595.6k | | 06/08/2017 |
| 05/25/2017 | PHASERX, INC. | PZRX | Grant | Employee Stock Option (right to buy) | 14k | $1.08 | $15.1k | | 05/25/2017 |
| 06/22/2016 | OPGEN INC | OPGN | Grant | Stock Option Award | 12.5k | $1.35 | $16.9k | | 06/22/2016 |
| 06/20/2016 | VERACYTE, INC. | VCYT | Grant | Stock Option (Right to Buy) | 10k | $5.28 | $52.8k | | 06/20/2016 |
| 06/09/2016 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 10k | $15.23 | $152.3k | | 06/09/2016 |
| 06/01/2016 | PHASERX, INC. | PZRX | Grant | Employee Stock Option (right to buy) | 28.2k | $5.08 | $143.3k | | 06/01/2016 |
| 05/23/2016 | PHASERX, INC. | PZRX | Sale | Common Stock | 435 | $0.01 | $4.4 | By Versant Side Fund III, L.P. | 05/23/2016 |
| 05/23/2016 | PHASERX, INC. | PZRX | Sale | Common Stock | 1.1k | $0.01 | $10.8 | By Versant Side Fund III, L.P. | 05/23/2016 |
| 05/23/2016 | PHASERX, INC. | PZRX | Purchase | Common Stock | 3.5k | $5.00 | $17.6k | By Versant Side Fund III, L.P. | 05/23/2016 |
| 05/23/2016 | PHASERX, INC. | PZRX | Sale | Common Stock | 73.6k | $0.01 | $736.2 | By Versant Venture Capital III, L.P. | 05/23/2016 |
| 05/23/2016 | PHASERX, INC. | PZRX | Sale | Common Stock | 182.9k | $0.01 | $1.8k | By Versant Venture Capital III, L.P. | 05/23/2016 |
| 05/23/2016 | PHASERX, INC. | PZRX | Purchase | Common Stock | 596.5k | $5.00 | $3M | By Versant Venture Capital III, L.P. | 05/23/2016 |
|
|